Global Dermal Fillers Market was Valued at US$ 3.2 Bn in 2017, Due To Growing Demand For The Aesthetic Procedures
London, UK -- (SBWIRE) -- 11/09/2018 -- "The Global Dermal Fillers Market was valued around US$ 3.2 Bn by 2017 and growing at a significant CAGR over seven years forecast period 2018-2024 owing to grow in prevalence of dermatology cases"
Precision Business Insights (PBI) in its report titled "Global Dermal Fillers Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024" assesses the market performance over seven years forecast period over 2018-2024. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.
The global dermal fillers market was valued at US$ 3.2 Bn in 2017 and increasing at a significant CAGR over the forecast timeframe due to surge in the incidence of various dermatological issues such as deep lines, wrinkles and scars in various countries around the world. Moreover, rise in number of aging population, increase in the demand for minimally-invasive or non-invasive surgical procedures, and technological advancements in the treatment procedures are expected to drive the global dermal fillers market. However, high cost for the dermatological treatment procedure and post-procedure complications are projected to hamper the revenue share of global dermal fillers market.
Sample of this report is available upon request @
Global dermal fillers market segmented on the basis of product type, ingredient type, distribution channel, and region
Hyaluronic Acid Dermal Fillers Dominate the Global Dermal Fillers Market
Based on the ingredient type, global dermal fillers market segmented into hyaluronic acid, poly-L-lactic acid, calcium hydroxylapatite, polymethylmethacrylate, collagen and others. Hyaluronic acid dermal fillers dominated the global market from past few years and estimated to dominate over the forecast period owing to rise in the adoption of hyaluronic acid derivatives due to their ability to attract the water molecules and helps in hydration of the skin. Furthermore, hyaluronic acid dermal fillers have less side effects when compared with the other dermal filler products. Moreover, launch of newer hyaluronic acid products into market also helps to enhance the revenue share in global dermal fillers market.
North America Leads the Global Dermal Fillers market
PBI's global dermal fillers market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis, North America accounted for larger revenue share through 2013-2017 and expected to dominate over 2018-2024 owing to surge in the number of dermatological treatment procedures, rise in demand for non-invasive or minimally-invasive aesthetic procedures, increase in aged population, and growing healthcare expenditure are projected to propel the market. Europe dermal fillers market projected to exhibit significant growth due to rise in incidence of dermatology patients and rise in skin treatment applications are expected to bolster the market. Furthermore, countries like South Korea, China, and Brazil are projected to registered higher growth rates when compared with other countries.
TOC of this report is available upon request @
Launch of newer products, novel indications and strategic alliances are the key strategies adopted by market players
Global dermal fillers market further reveals that the key players increasingly adopting strategies such as launch of newer products, novel indications and long term alliance to improve market revenue share and entering into the new markets. For instance. In 2015, Allergan plc, received approval from the U.S.FDA to market its juvederm ultra XC injection used for lip augmentation in adults over the age of 21.
Key player's profiles in the report are Galderma (Nestle) (Switzerland), Bioha Laboratories (China), Merz Pharma GmbH & CO. KGAA (Germany), Syneron Inc.(U.S.), Allergan plc (Ireland), AQTIS Medical (Canada), Teoxane Laboratories (Switzerland), Prollenium Medical Technologies Inc.,(U.S) and Suneva Medical (U.S.)
Ask Analyst for Full Information about this report @
By Product Type
o Absorbable Dermal Fillers
o Non-Absorbable Dermal Fillers
By Ingredient Type
o Hyaluronic Acid (HLA)
o Poly-L-Lactic Acid (PLA)
o Calcium Hydroxylapatite (CaH)
o Polymethylmethacrylate (PMMA)
By Distribution Channel
o Retail Pharmacies
o Beauty Clinics
o Online Pharmacies
o North America
- Rest of Europe
- Australia & New Zealand
- ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
- South Korea
- Rest of Asia-Pacific
o Latin America
- Rest of Latin America
o Middle East and Africa (MEA)
- Gulf Cooperation Council (GCC) Countries
- South Africa
- Rest of MEA
Get access to full summary @
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
152 – 160 City Road,
London EC1V 2NX
Contact Person: Rajesh Babu
Role: Marketing Lead
Toll Free (US):+1-866-598-1553